Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Primary mechanisms of action include: Enhanced insulin secretion : GLP-1 receptor agonists stimulate glucose-dependent insulin release from pancreatic beta cells, meaning insulin secretion increases when blood glucose is elevated but not when glucose levels are normal or low, reducing hypoglycemia risk Suppressed glucagon secretion : These medications inhibit glucagon release from pancreatic alpha cells, decreasing hepatic glucose production Delayed gastric emptying : GLP-1 receptor activation slows the rate at which food leaves the stomach, moderating postprandial glucose excursions Central appetite regulation : GLP-1 receptors in the brain, particularly in areas controlling satiety and food reward, are activated, leading to reduced appetite and caloric intake These combined effects result in improved glycemic control in patients with type 2 diabetes and significant weight loss in both diabetic and non-diabetic individuals
People assume I should be able to manage my weight perfectly because of my career
Veterans with obesity report poorer health status and more disability days compared to veterans without obesity
Many patients find it helpful to commence therapy at a weekend or during a period with fewer commitments, allowing time to monitor early side effects such as nausea
To view a copy of this license, visit About this article Cite this article Zhou, XD., Wong, V.WS
18, 2025.Starting in January, public workers and retirees enrolled in Group Insurance Commission plans will need to participate in a new program to maintain coverage for GLP-1 prescriptions, as the agency looks to alleviate another significant budget shortfall prompted in part by soaring costs of popular weight-loss drugs
US$ 22.85
US$ 27.20
US$ 21.63
